You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

CLINICAL TRIALS PROFILE FOR UBROGEPANT


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for UBROGEPANT

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02828020 ↗ Efficacy, Safety, and Tolerability Study of Oral Ubrogepant in the Acute Treatment of Migraine Completed Allergan Phase 3 2016-07-22 This study will evaluate the efficacy, safety, and tolerability of 2 doses of ubrogepant (50 and 100 mg) compared to placebo for the acute treatment of a single migraine attack.
NCT02867709 ↗ Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine Completed Allergan Phase 3 2016-08-26 This study will evaluate the efficacy, safety, and tolerability of 2 doses of ubrogepant (25 and 50 mg) compared to placebo for the acute treatment of a single migraine attack.
NCT02873221 ↗ An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine Completed Allergan Phase 3 2016-09-13 This study will evaluate the long-term safety and tolerability of intermittent treatment with ubrogepant for the acute treatment of migraine over 1 year.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for UBROGEPANT

Condition Name

Condition Name for UBROGEPANT
Intervention Trials
Migraine 6
Migraine, With or Without Aura 3
Migraine With Aura 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for UBROGEPANT
Intervention Trials
Migraine Disorders 11
Headache 1
Migraine without Aura 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for UBROGEPANT

Trials by Country

Trials by Country for UBROGEPANT
Location Trials
United States 225
Belgium 1
Denmark 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for UBROGEPANT
Location Trials
Missouri 8
Florida 8
Utah 7
Texas 7
Tennessee 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for UBROGEPANT

Clinical Trial Phase

Clinical Trial Phase for UBROGEPANT
Clinical Trial Phase Trials
Phase 4 3
Phase 3 6
Phase 1 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for UBROGEPANT
Clinical Trial Phase Trials
Not yet recruiting 6
Completed 5
Recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for UBROGEPANT

Sponsor Name

Sponsor Name for UBROGEPANT
Sponsor Trials
Allergan 9
AbbVie 2
Chicago Headache Center & Research Institute 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for UBROGEPANT
Sponsor Trials
Industry 11
Other 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.